Guangdong, China

Cheng Chen

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 1.3

ph-index = 2

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: Cheng Chen: Innovator in Biomedicine

Introduction

Cheng Chen is a prominent inventor based in Guangdong, China. He has made significant contributions to the field of biomedicine, particularly in the development of innovative therapeutic solutions. With a total of 6 patents to his name, his work has the potential to impact cancer treatment and immune system activation.

Latest Patents

One of Cheng Chen's latest patents is the "Anti-VEGF-anti-PD-L1 bispecific antibody, pharmaceutical composition of same, and uses thereof." This invention focuses on a bispecific antibody that includes a VEGF-targeted first protein functional area and a PD-L1-targeted second protein functional area. The first protein functional area can be an anti-VEGF antibody or a fragment thereof, while the second area is an anti-PD-L1 monoclonal antibody. This bispecific antibody is designed to activate the immune system and block tumor angiogenesis simultaneously, offering promising antitumor prospects.

Career Highlights

Cheng Chen has worked with notable companies such as Jinjiang Nuoyi Shoes Co., Ltd. and Biotheus Inc. His experience in these organizations has contributed to his expertise in biomedicine and innovation.

Collaborations

Cheng has collaborated with talented individuals like Xiaoniu Miao and Zhijun Yuan. These partnerships have likely enhanced his research and development efforts in the field.

Conclusion

Cheng Chen is a noteworthy inventor whose work in biomedicine is paving the way for new therapeutic approaches. His innovative patents reflect his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…